Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 51Neoplasms 36Lung Neoplasms 25Colorectal Neoplasms 24Prostatic Neoplasms 15Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Rectal Neoplasms 9Pancreatic Neoplasms 9Hematologic Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Anxiety Disorders 9Obesity 8Lymphoma 8Depression 8Endometrial Neoplasms 7Vulvar Neoplasms 6Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Melanoma 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Pain 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Smoking Cessation 4Papillomavirus Infections 4

Interventions

Methods 1Immunotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Cancer Liver Metastases × Methods × Clear all
NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Shandong Provincial Hospital

Phase 2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡